• Technology & Products3
    • Our Technology
    • eQUANT™
  • Under Development
  • News
  • Company
Contact us
  • Technology & Products3
    • Our Technology
    • eQUANT™
  • Under Development
  • News
  • Company
Contact us
  • Technology & Products3
    • Our Technology
    • eQUANT™
  • Under Development
  • News
  • Company
Contact Us
Avails Medical announces the commencement of U.S. Pilot Trial for the eAST™ system

Avails Medical announces the commencement of U.S. Pilot Trial for the eAST™ system

by Paula Adduci | Dec 3, 2024 | Press Releases

Published at PR Newswire View source MENLO PARK, CA, October 14, 2024 —Avails Medical, Inc., a leader in rapid, automated, and fully electrical antibiotic susceptibility testing (eAST™), announced today the launch of its U.S. pilot trial for the innovative eAST system...
Avails Medical announces the commencement of U.S. Pilot Trial for the eAST™ system

Avails Medical welcomes Dan Douglas as Vice President of Finance

by Paula Adduci | Nov 12, 2024 | Press Releases

Published at PR Newswire View source MENLO PARK, CA, October 14, 2024 —Avails Medical, Inc., a pioneer in rapid antibiotic susceptibility diagnostic innovations, is pleased to announce the appointment of Dan Douglas as the new Vice President of Finance. Dan joins...
Avails Medical announces the commencement of U.S. Pilot Trial for the eAST™ system

Mari Hoidal joins Avails Medical as Vice President of Marketing

by Paula Adduci | Oct 14, 2024 | Press Releases

Published at PR Newswire View source MENLO PARK, CA, October 14, 2024 —Avails Medical, Inc., a pioneer in accelerating antibiotic susceptibility testing (AST) solutions, is proud to announce the appointment of Mari Hoidal as Vice President of Marketing. With over 20...
Avails Medical Announces FDA Clearance of its eQUANT™ System to Accelerate Workflow for Antibiotic Susceptibility Testing

Avails Medical Announces FDA Clearance of its eQUANT™ System to Accelerate Workflow for Antibiotic Susceptibility Testing

by Paula Adduci | Feb 20, 2024 | Press Releases

Published at PR Newswire View source MENLO PARK, February 20, 2024 (Newswire.com) – Avails Medical, Inc., a leader in the development of rapid, automated and fully electrical antibiotic susceptibility testing (AST) technologies, announced it has received 510(k)...
Avails Medical’s eQUANT™ system submitted to FDA for 510(k) clearance

Avails Medical’s eQUANT™ system submitted to FDA for 510(k) clearance

by Paula Adduci | Jun 12, 2023 | Press Releases

MENLO PARK, Calif., June 12, 2023 /PRNewswire/ — Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (AST) solutions announced today the submission of its eQUANT™ system for FDA 510(k) clearance. The eQUANT system...
Avails Medical awarded additional $1.7M in CARB-X funding for the development of its rapid antibiotic susceptibility testing device to identify the most effective antibiotic therapy

Avails Medical awarded additional $1.7M in CARB-X funding for the development of its rapid antibiotic susceptibility testing device to identify the most effective antibiotic therapy

by Paula Adduci | Sep 1, 2022 | Press Releases

Published at PR Newswire View source MENLO PARK, Calif., Sept. 1, 2022 /PRNewswire/ — Avails Medical, a pioneer in rapid, automated, and fully electrical antibiotic susceptibility testing (eAST™) announced today the transition to the next phase of its CARB-X...
« Older Entries
Avails logo

Information

Company

News

Technology

Products

eQUANT™

Get in Touch

Contact us
Avails logo
Contact us

Information

Company

News

Technology

Products

eQUANT™

The eQUANT System is 510(k) cleared in the U.S. Not approved for other markets. The Rapid AST System is currently under development and is not available for sale in the U.S. or any other market.

© 2025 Avails Medical. All Rights Reserved. The brand names/logos featured herein are trademarks of Avails Medical or their respective owners. Any unauthorized use is expressly prohibited. See www.Avails.com/trademarks. Contact Us: (800) 931-4595

Trademarks     Patents     Terms of Use     Privacy Policy
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}